Results 21 to 30 of about 26,766 (239)

Ivermectin susceptibility and sporontocidal effect in Greater Mekong Subregion Anopheles

Malaria Journal, 2017
Background Novel vector control methods that can directly target outdoor malaria transmission are urgently needed in the Greater Mekong Subregion (GMS) to accelerate malaria elimination and artemisinin resistance containment efforts. Ivermectin mass drug
Kevin C. Kobylinski, Ratawan Ubalee, Alongkot Ponlawat, Chanyapat Nitatsukprasert, Siriporn Phasomkulsolsil, Thanaporn Wattanakul, Joel Tarning, Kesara Na-Bangchang, Patrick W. McCardle, Silas A. Davidson, Jason H. Richardson   +10 more
doaj   +1 more source

Plasma pharmacokinetic profile of fluralaner (Bravecto™) and ivermectin following concurrent administration to dogs

Parasites & Vectors, 2015
Background Fluralaner is a novel systemic ectoparasiticide for dogs providing immediate and persistent flea, tick and mite control after a single oral dose.
Feli M. Walther, Mark J. Allan, Rainer KA Roepke   +2 more
doaj   +1 more source

Ivermectin buyers clubs

New Scientist, 2021
People in the UK are trying to source a parasite drug to use as an unproven treatment for covid-19, reveals Chris Stokel-Walker.
openaire   +3 more sources

Ivermectin susceptibility, sporontocidal effect, and inhibition of time to re-feed in the Amazonian malaria vector Anopheles darlingi

Malaria Journal, 2017
Background Outdoor malaria transmission hinders malaria elimination efforts in the Amazon region and novel vector control tools are needed. Ivermectin mass drug administration (MDA) to humans kills wild Anopheles, targets outdoor-feeding vectors, and can
Kevin C. Kobylinski, Karín S. Escobedo-Vargas, Victor M. López-Sifuentes, Salomón Durand, Edward S. Smith, G. Christian Baldeviano, Robert V. Gerbasi, Sara-Blythe Ballard, Craig A. Stoops, Gissella M. Vásquez   +9 more
doaj   +1 more source

Ivermectin exposures reported to the Poisons Information Helpline in South Africa during the COVID-19 pandemic

South African Medical Journal, 2022
Background. Ivermectin is an antiparasitic drug that has shown in vitro activity against COVID‑19. Clinical studies supporting ivermectin for COVID‑19 prevention and treatment are conflicting, with important limitations. Public support for ivermectin is
V Pillay-Fuentes Lorente, G Voigt, C E du Plessis, K Balme, C J Marks, E H Decloedt, C Stephen, H Reuter, R van Rensburg   +8 more
doaj   +1 more source

Use of Ivermectin as a Potential Chemoprophylaxis for COVID-19 in Egypt: A Randomised Clinical Trial [PDF]

Journal of Clinical and Diagnostic Research, 2021
Introduction: The rate of secondary attacks of SARS-COV-2 is high among household close contacts. Social distancing, isolation and infection control measures are important for preventing exposure to infection, but insufficient.
Waheed M Shoumann, Abdelmonem Awad Hegazy, Ramadan M Nafae, Moustafa I Ragab, Saad R Samra, Dalia Anas Ibrahim, Tarek H AL-Mahrouky, Ashraf E Sileem   +7 more
doaj   +1 more source

Comparative effect of dose escalation of nanocapsulated ivermectin against mange in rabbits

German Journal of Veterinary Research, 2022
The present study aimed to investigate the effects of nano-capsulated ivermectin on the liver and kidney function and oxidative status in mite infested-rabbits, compared to ivermectin. Additionally, the ivermectin residue profile in adipose tissue, liver,
Azza Abdelmoteleb, Dalia Elmasry, Fatma Amro, Reham Mahmoud   +3 more
doaj   +1 more source

Comparison between the efficacy of ivermectin and other drugs in treatment of cutaneous leishmaniasis [PDF]

Iraqi Journal of Veterinary Sciences, 2009
The study was conducted to compare the efficacy of ivermectin with some drugs in treatment of cutaneous leishmaniasis in vitro and in Balb/ C mice. The cultivation of Leishmania tropica was done on Nove MacNeal-Nicole medium (NNN).
M. A. Kadir, H. S. Aswad, A. M. Al-Samarai and G. A. Al-Mula
doaj   +1 more source

Ivermectin Does Not Protect against SARS-CoV-2 Infection in the Syrian Hamster Model

Microorganisms, 2022
Ivermectin, an FDA-approved antiparasitic drug, has been reported to have in vitro activity against SARS-CoV-2. Increased off-label use of ivermectin for COVID-19 has been reported.
Caroline S. Foo, Rana Abdelnabi, Laura Vangeel, Steven De Jonghe, Dirk Jochmans, Birgit Weynand, Johan Neyts   +6 more
doaj   +1 more source

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?

Infectious Diseases of Poverty, 2019
Background There is accumulating evidence supporting the use of ivermectin as a malaria control tool. Recent findings from the repeat ivermectin mass drug administrations for control of malaria trial demonstrated a reduced incidence of malaria in ...
Joseph Nelson Siewe Fodjo, Marina Kugler, An Hotterbeekx, Adam Hendy, Jean-Pierre Van Geertruyden, Robert Colebunders   +5 more
doaj   +1 more source